CRBP
Price
$6.18
Change
-$0.32 (-4.92%)
Updated
Dec 4, 6:59 PM EST
SRZN
Price
$0.52
Change
+$0.02 (+4.08%)
Updated
Dec 4, 6:59 PM EST
107 days until earnings call
Ad is loading...

Analysis and predictions CRBP vs SRZN

Header iconCRBP vs SRZN Comparison
Open Charts CRBP vs SRZNBanner chart's image
Corbus Pharmaceuticals Holdings
Price$6.18
Change-$0.32 (-4.92%)
Volume$8.1K
CapitalizationN/A
Surrozen
Price$0.52
Change+$0.02 (+4.08%)
Volume$28.43K
CapitalizationN/A
View a ticker or compare two or three
CRBP vs SRZN Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CRBP vs. SRZN commentary
Dec 05, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBP is a StrongSell and SRZN is a StrongBuy.

COMPARISON
Comparison
Dec 05, 2023
Stock price -- (CRBP: $6.18 vs. SRZN: $0.52)
Brand notoriety: CRBP and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBP: 89% vs. SRZN: 79%
Market capitalization -- CRBP: $18.62M vs. SRZN: $13.71M
CRBP [@Biotechnology] is valued at $18.62M. SRZN’s [@Biotechnology] market capitalization is $13.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBP’s FA Score shows that 0 FA rating(s) are green whileSRZN’s FA Score has 1 green FA rating(s).

  • CRBP’s FA Score: 0 green, 5 red.
  • SRZN’s FA Score: 1 green, 4 red.
According to our system of comparison, SRZN is a better buy in the long-term than CRBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBP’s TA Score shows that 4 TA indicator(s) are bullish while SRZN’s TA Score has 7 bullish TA indicator(s).

  • CRBP’s TA Score: 4 bullish, 5 bearish.
  • SRZN’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SRZN is a better buy in the short-term than CRBP.

Price Growth

CRBP (@Biotechnology) experienced а +46.79% price change this week, while SRZN (@Biotechnology) price change was +15.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.40%. For the same industry, the average monthly price growth was +26.79%, and the average quarterly price growth was +25.75%.

Reported Earning Dates

CRBP is expected to report earnings on May 11, 2023.

SRZN is expected to report earnings on Mar 21, 2024.

Industries' Descriptions

@Biotechnology (+5.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CRBP with price predictions.
OPEN
A.I.dvisor published
a Summary for SRZN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRBP($18.6M) has a higher market cap than SRZN($13.7M). CRBP YTD gains are higher at: 86.425 vs. SRZN (-11.119). SRZN has higher annual earnings (EBITDA): -33.58M vs. CRBP (-37.82M). SRZN has more cash in the bank: 43.4M vs. CRBP (28.7M). SRZN has less debt than CRBP: SRZN (3.96M) vs CRBP (22.9M). SRZN has higher revenues than CRBP: SRZN (12.5M) vs CRBP (0).
CRBPSRZNCRBP / SRZN
Capitalization18.6M13.7M136%
EBITDA-37.82M-33.58M113%
Gain YTD86.425-11.119-777%
P/E RatioN/AN/A-
Revenue012.5M-
Total Cash28.7M43.4M66%
Total Debt22.9M3.96M578%
FUNDAMENTALS RATINGS
CRBP: Fundamental Ratings
CRBP
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBPSRZN
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACOR10.870.55
+5.34%
Acorda Therapeutics
SMID33.510.79
+2.41%
Smith-Midland Corp
CTBI42.080.72
+1.74%
Community Trust Bancorp
TDOC19.030.06
+0.32%
Teladoc Health
FITB30.650.07
+0.23%
Fifth Third Bancorp

CRBP and

Correlation & Price change

A.I.dvisor tells us that CRBP and CGTX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRBP and CGTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBP
1D Price
Change %
CRBP100%
-4.92%
CGTX - CRBP
32%
Poorly correlated
+14.17%
MOR - CRBP
28%
Poorly correlated
+2.85%
AMPE - CRBP
27%
Poorly correlated
-17.08%
ANVS - CRBP
27%
Poorly correlated
+16.02%
SRZN - CRBP
26%
Poorly correlated
+5.55%
More

SRZN and

Correlation & Price change

A.I.dvisor tells us that SRZN and GRTX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRZN and GRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRZN
1D Price
Change %
SRZN100%
+5.55%
GRTX - SRZN
31%
Poorly correlated
-3.17%
CRBP - SRZN
26%
Poorly correlated
-4.92%
BRNS - SRZN
25%
Poorly correlated
-4.44%
PTIX - SRZN
23%
Poorly correlated
+4.58%
VSTM - SRZN
22%
Poorly correlated
+5.99%
More